New anesthetic patch available in second quarter

Article

S

Endo Pharmaceuticals has obtained the rights from Zars Pharma for Synera (lidocaine 70 mg/tetracaine 70 mg) topical patch. The new product was approved by the FDA in June 2005 and is used on intact skin to provide local dermal anesthesia for venous access and superficial dermatological procedures in both adults and children. Synera should be applied 20 to 30 minutes prior to the procedure and contains an oxygen-activated heating element that warms the skin in addition to providing pain relief. Synera should be commercially available in the second half of 2006.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series
Image Credit: jokekung - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.